New York, United States
Athyrium Capital is a specialized asset management company with a focus on the global healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations.
31
Total Investments
28
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Finance, Financial Services
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Athyrium Capital Management
Recent Investments (31)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Jan 2024 | |
| Post-IPO Debt | •••••• | Dec 2023 | |
| Post-IPO Debt | •••••• | Sep 2022 | |
| Series B | •••••• | May 2022 | |
| Post-IPO Equity | •••••• | Mar 2022 | |
•••• ••••
|
Post Ipo Debt | •••••• | Mar 2022 |
|
•••• ••••
|
Post-IPO Debt | •••••• | Oct 2021 |
|
•••• ••••
|
Post-IPO Debt | •••••• | Jul 2021 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Dec 2020 |
|
•••• ••••
|
Post-IPO Debt | •••••• | Dec 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
